Crohn's Disease Activity Index (CDAI)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۲۰۰ • واحد: count
حداقل ۱۰ — حداکثر ۶۰ • واحد: percentage
حداقل ۳۰ — حداکثر ۳۰۰ • واحد: kg
حداقل ۳۰ — حداکثر ۳۰۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Remission0–149
- Mild Disease150–219
- Moderate Disease220–299
- Severe Disease300–450
The Crohn's Disease Activity Index (CDAI) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include liquid stools week. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Quantifies disease activity in Crohn's disease patients using clinical symptoms and laboratory findings over a 7-day period
Clinical Indication
The Crohn's Disease Activity Index (CDAI) is indicated for bedside clinical practice to support Quantifies disease activity in Crohn's disease patients using clinical symptoms and laboratory findings over a 7-day period. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: A decrease of ≥70 points is considered a significant response to treatment.
CDAI = (Liquid stools × 2) + (Abdominal pain × 5) + (General well-being × 7) + (Extraintestinal complications × 20) + (Antidiarrheal use × 30) + (Abdominal mass × 10) + (Hematocrit deficit × 6) + (Weight deficit × 1)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| liquid_stools_week | integer | Yes | Total number of liquid or loose stools over the past 7 days (patient diary)(count) |
| abdominal_pain_score | string | Yes | Average daily abdominal pain rating over the past 7 days (0=none, 1=mild, 2=moderate, 3=severe)(score) |
| general_wellbeing_score | string | Yes | Average daily general well-being rating over the past 7 days (0=generally well, 1=slightly under par, 2=poor, 3=very poor, 4=terrible)(score) |
| arthritis_arthralgias | string | Yes | Presence of arthritis or arthralgias (joint pain/inflammation)(presence) |
| iritis_uveitis | string | Yes | Presence of iritis or uveitis (eye inflammation)(presence) |
| erythema_nodosum | string | Yes | Presence of erythema nodosum (skin inflammation)(presence) |
| anal_fissure_fistula | string | Yes | Presence of anal fissure, fistula, or abscess(presence) |
| other_fistulas | string | Yes | Presence of other fistulas (excluding anal)(presence) |
| fever | string | Yes | Fever >37.8°C (100°F) during the past 7 days(presence) |
| antidiarrheal_use | string | Yes | Use of antidiarrheal medications (loperamide, diphenoxylate) during the past 7 days(presence) |
| abdominal_mass | string | Yes | Presence of abdominal mass on physical examination (0=none, 2=questionable, 5=definite)(presence) |
| patient_sex | string | Yes | Patient biological sex (for expected hematocrit calculation)(sex) |
| observed_hematocrit | float | Yes | Current hematocrit percentage (laboratory value)(percentage) |
| current_weight | float | Yes | Current body weight in kilograms(kg) |
| ideal_weight | float | Yes | Ideal body weight in kilograms (calculated or estimated)(kg) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–149 | Remission | Clinical remission |
| 150–219 | Mild Disease | Mild disease activity |
| 220–299 | Moderate Disease | Moderate disease activity |
| 300–450 | Severe Disease | Severe disease activity |
| 451–600 | Very Severe Disease | Very severe disease activity |
Evidence-Based References (EBM)
- Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439-444.
- Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122(2):512-530.
- Jørgensen LG, Fredholm L, Hyltoft Petersen P, et al. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med. 2005;43(4):403-411.